圣桐特医递表港交所 中信证券为独家保荐人

Core Viewpoint - The company, 圣桐特医, has submitted an application for listing on the Hong Kong Stock Exchange, positioning itself as a leading provider of specialized medical foods in China, with CITIC Securities as the sole sponsor [1] Group 1: Market Position - As of 2024, 圣桐特医 holds the top position among domestic specialized medical food brands in China, with a market share of 6.3%, ranking fourth among all specialized medical food brands [1] - In the infant specialized medical food market, the company also leads among domestic brands, achieving a market share of 9.5%, ranking third overall [1] Group 2: Company Milestones - Established in 2005, 圣桐特医 was one of the first companies in China to create a specialized medical food department and became the first Chinese brand to commercialize specialized medical food products in 2007 [1] - The company was the first in China to receive approval for the production of specialized medical food products in 2011 [1] - In January 2025, the company received registration certificates for "特爱丙佳," the first and only specialized medical food for infants with propionic acidemia or methylmalonic acidemia, and "特爱本佳," the first specialized medical food for infants with phenylketonuria developed by a Chinese brand [1] Group 3: Product Development - As of November 25, 2025, 圣桐特医 has launched 14 major specialized medical food products, with an additional 16 major new products currently in development [1] - The company holds the highest number of registration certificates for infant specialized medical foods among Chinese brands [1]